Long non-coding RNA MALAT1 protects against Aβ1–42 induced toxicity by regulating the expression of receptor tyrosine kinase EPHA2 via quenching miR-200a/26a/26b in Alzheimer's disease
- 19 May 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 302, 120652
Abstract
No abstract availableKeywords
Funding Information
- Homi Bhabha National Institute
- Department of Atomic Energy, Government of India
This publication has 70 references indexed in Scilit:
- Alteration of the microRNA network during the progression of Alzheimer's diseaseEMBO Molecular Medicine, 2013
- A blood based 12-miRNA signature of Alzheimer disease patientsGenome Biology, 2013
- Involvement of Receptor Tyrosine Kinase Tyro3 in Amyloidogenic APP Processing and β-Amyloid Deposition in Alzheimer's Disease ModelsPLOS ONE, 2012
- Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neuronsMolecular Neurodegeneration, 2011
- Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 DiabetesArchives of Neurology, 2011
- Reversing EphB2 depletion rescues cognitive functions in Alzheimer modelNature, 2010
- A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expressionThe EMBO Journal, 2010
- Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway HypothesisNeuron, 2008
- Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascadeOncogene, 2002
- Nuclear and Cytoplasmic Localization of the β-Amyloid Peptide (1–43) in Transfected 293 CellsBiochemical and Biophysical Research Communications, 1996